The White House is drafting an executive order on the disproven link between vaccines and autism, according to independent reports from The Washington Post and Bloomberg, which both cited unnamed sources with knowledge of the efforts.

Bloomberg reported that the executive order, which is still taking shape and is subject to change, could be issued as soon as next week. The Post said the order's drafting so far is aimed at the childhood vaccine schedule, autism research, and parental choice for vaccinations.

Dozens of high-quality studies encompassing data from millions of children worldwide have already been carried out on the topic and have consistently found no link between childhood vaccines and autism. The claim of a link stems from an unethical, fraudulent study that was retracted years ago, and its author was stripped of his medical license.

Read full article

Comments

© Getty | Tom Brenner

As AI reshapes the way we communicate, researchers at Texas A&M University are developing an artificial intelligence-powered platform that could transform care for children with autism and older adults living with dementia. The technology learns each person’s unique communication style, behaviors, and preferences, enabling increasingly personalized support for caregivers, therapists, and families over time.

Called VoiceLove, it is one of three projects being developed with support from the Advanced Research Projects Agency for Health (ARPA-H).

At the core of the system is an AI engine that analyzes both speech and nonverbal behaviors documented through short videos recorded by caregivers or therapists during daily communications and interactions. Rather than comparing participants against a general model, the platform focuses on understanding each person’s individual patterns and communication style.

“Every child with autism is unique, and effective support should reflect that,” he said. “Our project leverages artificial intelligence to understand each child’s individual behaviors, communication styles, and preferences. The goal is to deliver personalized recommendations that help families, educators, and clinicians work together more effectively, enabling more responsive, data-driven care and improving the health and well-being of children with autism,” says Dr. Junhyoung Kim, associate professor in the School of Public Health, one of the principal investigators on the project, in a statement. 

The AI system was created to identify behavioral patterns in communication, interests, and responses across different situations. Based on its observations, the program provides personalized recommendations that could help therapists or caregivers create individualized intervention plans.

“The key innovation behind this platform is its ability to understand each child individually and learn their unique preferences, needs, communication styles, and strengths to deliver personalized recommendations,” Kim said. “For people living with dementia, the platform is designed to enhance person-centered care by helping residents communicate their needs, preferences, and daily experiences more effectively.”

Researchers say the technology could support a wide range of developmental goals, including improving communication skills, encouraging self-care, strengthening social engagement, and enhancing a person’s quality of life.

The same personalized approach could also benefit people living with dementia, where communication challenges often make it difficult for individuals to express their needs and wants. 

“Our vision is to create an AI platform that continuously learns from each child’s daily experiences,” Kim said. “As the system identifies patterns in behaviors, preferences, and responses to different activities, it can provide therapists and caregivers with personalized recommendations that evolve over time.”

“This adaptive approach helps explain why certain behaviors occur and supports more individualized, proactive care,” Kim added. 

VoiceLove is designed to keep learning. As caregivers continue using the app, the AI analyzes new interactions while also incorporating caregiver observations, experiences, and responses to daily prompts. 

The research team plans to begin with a small pilot study involving children with autism and older adults living with dementia after receiving Institutional Review Board approval.

Participants will use the platform for approximately one month while researchers evaluate its usability, feasibility, and overall user experience, and from there, insights derived from the pilot will help to inform a larger-scale study at some point in the future. 

Chrissy Newton is a PR professional and the founder of VOCAB Communications. She currently appears on The Discovery Channel and Max and hosts the Rebelliously Curious podcast, which can be found on YouTube and on all audio podcast streaming platforms. Follow her on X: @ChrissyNewton, Instagram: @BeingChrissyNewton, and chrissynewton.com. To contact Chrissy with a story, please email chrissy @ thedebrief.org.

A new study reporting in Translational Psychiatry suggests that a traditional medicinal formulation called Rannasangpei—and particularly its constituent crocin-1—may help blunt autism-like behaviors triggered by prenatal exposure to valproic acid (VPA). The work frames autism-related impairments not only as behavioral phenomena, but also as downstream consequences of disrupted redox balance and chronic neuroinflammatory signaling in the brain.

The researchers used a VPA-induced model to mimic key aspects of autism-like neurodevelopmental disruption. Within this framework, they assessed whether Rannasangpei components could restore biological stability and translate into measurable improvements in behavior. The experimental logic is straightforward: if oxidative stress and neuroinflammation are causal amplifiers, then reducing them should lead to behavioral rescue.

A central finding is that treatment with Rannasangpei correlated with reduced oxidative stress markers. Oxidative stress is increasingly viewed as a bridge between genetic/environmental risk and neuronal dysfunction, because reactive oxygen species can disturb synaptic integrity, neuronal maturation, and signaling cascades essential for social and cognitive behaviors.

Equally important, the study reports a suppression of neuroinflammation. Neuroinflammation can reshape neural circuits through glial activation and altered cytokine profiles, potentially worsening developmental trajectories. By dampening inflammatory responses, crocin-1–linked effects appear to protect the brain environment during a sensitive developmental window.

The authors also emphasize that crocin-1’s contribution is not merely supportive but functionally significant, consistent with the bioactive chemistry of crocins that have been studied for antioxidant and anti-inflammatory activity. In this sense, the paper positions crocin-1 as a mechanistic candidate within a multi-component formulation.

Importantly for translational enthusiasm, the results connect molecular readouts to behavior, strengthening the argument that the observed changes are not cosmetic. Instead, they suggest an integrated pathway: oxidative imbalance and inflammatory tone shift in parallel with autism-like phenotype severity.

Overall, the study adds to a growing viral science-news narrative in neurodevelopment: natural compounds may modulate the biological “stress–inflammation” axis that shapes risk models like VPA. While animal data cannot be directly generalized to humans, the mechanistic coherence makes crocin-1 and Rannasangpei an attention-worthy direction for future preclinical and clinical exploration.

In the meantime, the headline is clear: Rannasangpei and crocin-1 show promise in reducing VPA-induced autism-like behaviors by calming oxidative stress and neuroinflammation, bringing a traditional medicine ingredient into modern neurobiological spotlight.

Subject of Research: Autism-like behaviors induced by valproic acid; oxidative stress and neuroinflammation
Article Title: Rannasangpei and its constituent crocin-1 ameliorate valproic acid–induced autism-like behaviors accompanied by reduced oxidative stress and neuroinflammation.
Article References: Qiu, R., Li, L., Yao, T. et al. Transl Psychiatry (2026). https://doi.org/10.1038/s41398-026-04283-0
Image Credits: AI Generated
DOI: https://doi.org/10.1038/s41398-026-04283-0

In a groundbreaking study poised to redefine early interventions in autism spectrum disorder (ASD), researchers have unveiled new insights into the intricate interplay between brain development and behavioral patterns that forecast spoken vocabulary acquisition in young children with autism. Published in Translational Psychiatry in 2026, this pioneering work merges multimodal neuroimaging with detailed behavioral assessments, offering a nuanced understanding of how early childhood brain and behavioral markers converge to shape language outcomes in this population.

The study tackles one of the most perplexing facets of autism—the vast variability in language development, particularly spoken vocabulary. Language acquisition in children with ASD is notoriously heterogeneous, with some children progressing to age-appropriate speech while others remain nonverbal or develop only limited vocabularies. The research team, led by Surgent, Naigles, Dakopolos, and colleagues, conceptualized a multimodal predictive framework that integrates neurological data and observable behaviors, an approach that promises to yield more precise individual prognoses.

Central to their methodology was the utilization of advanced neuroimaging techniques during early childhood to evaluate brain structure and connectivity. These imaging modalities included diffusion tensor imaging (DTI), functional magnetic resonance imaging (fMRI), and volumetric analyses that together painted a comprehensive picture of the neural substrates critical for language processing. Specifically, measures of white matter integrity in tracts such as the arcuate fasciculus, known for its role in language networks, offered predictive value regarding the trajectory of vocabulary growth.

Parallel to imaging, the researchers conducted rigorous behavioral observations, focusing on early communicative attempts, joint attention, and social engagement metrics. These behavioral indices serve as functional readouts of the developing brain’s linguistic capacity and its interaction with the child’s environment. The amalgamation of brain imaging metrics with behavioral data created a rich dataset enabling machine learning algorithms to identify patterns that standard clinical assessments might overlook.

One of the most compelling revelations of this research came from the combined predictive power of brain-behavior models as opposed to isolated measures. While previous studies have often considered either neurobiological markers or behavioral indicators in silos, this study demonstrated that an integrative model significantly enhances prediction accuracy for spoken vocabulary outcomes months to years in advance. This finding signals a paradigm shift in early diagnosis and intervention planning, suggesting that multimodal data collection should become standard practice.

The implications for clinical application are profound. Accurate early prediction of language development trajectories using this multimodal approach could allow clinicians and caregivers to tailor intervention strategies with unprecedented specificity. For instance, children flagged as likely to experience more significant language delays might receive intensified speech and language therapies, while those predicted to gain vocabularies at typical rates could benefit from less intensive, yet still supportive, programs. This targeting aligns resources more efficiently and helps optimize developmental outcomes.

Moreover, the study illuminated potential neurobiological mechanisms underlying the language profiles seen in autism. White matter pathways supporting auditory-motor integration, semantic processing, and syntactic construction were shown to exhibit differing maturation trajectories in children with more favorable vs. impaired vocabulary development. These findings hint at critical windows during which neural plasticity interventions might be most effective, informing future trials of neurotherapeutics or brain stimulation techniques.

Beyond therapeutic considerations, the research also advances fundamental understanding of autism itself by underscoring how language acquisition is modeled through complex brain networks and shaped by early communicative behaviors. The integration of structural and functional brain data with real-world social and language behaviors accentuates the bidirectional and dynamic nature of neurodevelopment in ASD, challenging static conceptualizations that have predominated in the field.

The authors further caution that while predictive models are promising, ethical considerations around prognostic information for families must be carefully managed. Delivering predictions about language outcomes is profoundly impactful, necessitating sensitive communication, counseling support, and ongoing monitoring to adjust interventions as children grow and contexts change. The study emphasizes that predictive algorithms are tools to augment, not replace, clinical judgment.

Complementing their scientific contributions, the study’s open-access dissemination via a reputed neuroscience journal ensures rapid accessibility to clinicians, researchers, and policy makers worldwide. The transparency of methods and availability of anonymized data for secondary analyses encourage replication and cross-validation, fostering accelerated progress in autism research ecosystems.

Looking forward, the research team envisions expanding their multimodal approach to encompass other domains of development affected in autism, such as social cognition, executive function, and adaptive behavior. Integrating additional biomarker modalities like genomics and metabolomics could further refine individualized predictions and catalyze precision medicine initiatives in neurodevelopmental disorders.

In sum, this seminal study marks a critical advance in unraveling the complex nexus between brain maturation, behavioral development, and language acquisition in autism. Its innovative multimodal framework sets a new standard for early prediction and personalized intervention, offering hope for improving long-term communicative outcomes for children with ASD worldwide. As science continues to decode the developing autistic brain, such integrative approaches will be instrumental in bridging biology and behavior to transform lives.

---

Subject of Research: Early childhood brain and behavior predictors of spoken vocabulary development in autism

Article Title: Multimodal predictors of spoken vocabulary development in autism: the role of early childhood brain and behavior

Article References:
Surgent, O., Naigles, L., Dakopolos, A. et al. Multimodal predictors of spoken vocabulary development in autism: the role of early childhood brain and behavior. Transl Psychiatry (2026). https://doi.org/10.1038/s41398-026-04168-2

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41398-026-04168-2

Emerging insights into autism spectrum disorder (ASD) have been propelled forward by an innovative study examining cortical development dynamics using multiple mouse models. This work delves deeply into the transcriptional landscapes shaped by mutations implicated in ASD, revealing a complex interplay of stage-specific and genotype-specific molecular signatures. Employing cutting-edge network colocalization analyses and protein–protein interaction mapping, the study illuminates how biological processes converge and diverge during neurodevelopment in mutant genotypes.

Fundamentally, the research builds upon gene set enrichment analysis (GSEA), which previously highlighted overlapping pathways across various ASD-related mutations. The researchers expanded on this by applying network colocalization analysis to protein interaction networks, allowing functionally related proteins to be grouped into clusters through sophisticated averaging of random walks. This methodological advancement enables a nuanced assessment of expression changes aggregated at the systems-level rather than focusing solely on individual genes.

At the heart of their findings is the identification of distinct yet overlapping patterns of molecular dysregulation during critical developmental stages, particularly embryonic day 14.5 (E14.5), postnatal day 4 (P4), and postnatal day 14 (P14). At E14.5, the study reveals that mutations such as those in HnrnpU and Kdm6b robustly influence pathways tied to the actin cytoskeleton, cell proliferation, and division within excitatory neurons. Notably, these effects also extend, to a lesser degree, to Cul3 mutants, aligning with earlier evidence suggesting these genes’ involvement in neurodevelopmental regulation.

Delving deeper, the analysis highlights a provocative role of WNT signaling, especially pronounced in HnrnpU and Kdm6b variants. WNT pathways are critical for neural patterning and synaptogenesis, and their disruption could underpin some ASD phenotypes. This novel perspective accentuates the shared mechanistic underpinnings of ASD mutations converging on fundamental developmental pathways, stressing the importance of timing within neurodevelopmental trajectories.

Postnatally, at P4 and P14, the transcriptional alterations shift noticeably towards synaptic functions, ion transport, and metabolic processes—markers of neuronal specialization and circuit maturation. The data demonstrate how the influence of mutations evolves alongside neural differentiation and maturation. Intriguingly, Kmt5b mutants exhibited an inverse pattern at P4, suggesting either a compensatory or opposing regulatory role within the shared pathways affected across mutants. This counterintuitive finding raises the possibility of complex feedback or adaptive mechanisms operating in ASD-linked genetic variants.

By P14, metabolic processes prominently emerge in the affected molecular networks, especially in Bckdk, HnrnpU, and Trip12 mutants, indicating that energy metabolism perturbations may be integral to ASD pathogenesis. These results underscore the temporal dynamics of how genetic mutations impinge upon neurodevelopment, transitioning from early cytoskeletal and proliferative effects to later synaptic and metabolic modulation.

The study also innovatively explores how differentially expressed genes from each genotype localize within the interactome network and assesses similarity across developmental stages and mutations. This reveals a compelling developmental-stage-dependent pattern where transcriptional signatures cluster more closely within each stage but become more genetically distinct by P14. Such divergence suggests that while ASD mutations initially impact common biological processes, their influence fragments into distinct genotype-specific programs as development proceeds.

These findings have broad implications for understanding ASD heterogeneity and the challenges of developing universal therapeutic interventions. The discovery of both shared and unique pathway disruptions at different developmental times suggests treatment strategies may need to be tailored to both genotype and developmental timing to maximize efficacy. Moreover, the role of metabolic dysregulation invites further exploration into metabolic interventions or dietary modulation as adjunctive strategies.

Critically, the network colocalization analysis used represents a powerful approach to dissecting complex genetic disorders. By moving beyond simple gene expression differences and integrating system-level interactions, researchers can better capture the multifaceted nature of neurodevelopmental perturbations characteristic of ASD. This systems biology approach is likely to prove invaluable in future studies dissecting the molecular bases of brain disorders.

The comprehensive nature of this study, which integrates multiple ASD-relevant mouse models, enables the identification of convergent and divergent mechanisms with precision. It highlights how individual genes implicated in autism can distinctly alter transcriptional landscapes depending on context, highlighting the multifactorial dimension of ASD. Additionally, it underscores that the timing of gene dysregulation is paramount, with early embryonic disruptions cascading into diverse neurodevelopmental consequences.

In sum, this landmark investigation offers a rich, dynamic map of the molecular trajectories altered by ASD mutations across cortical development. Its integration of genomic, proteomic, and network analyses provides a blueprint for future research aimed at unraveling the complexity of neurodevelopmental disorders. By elucidating how multiple risk genes influence overlapping yet unique biological processes during critical developmental windows, the study charts a path toward precision medicine in autism spectrum disorder.

As the field progresses, leveraging such multi-dimensional analytical frameworks will be essential for translating genetic discoveries into mechanistic insights and targeted therapies. This work also highlights the ongoing need to examine neurodevelopment through temporal and molecular lenses simultaneously, enriching our understanding of how genetic diversity shapes brain development and function. Ultimately, investigations like these nurture hope for deciphering the intricate biology underlying ASD and devising effective interventions tailored to individual developmental trajectories.

Subject of Research: Cortical development dynamics and molecular mechanisms in autism spectrum disorder mouse models.

Article Title: Cortical development dynamics across autism spectrum disorder mouse models.

Article References:
Schwarz, L.A., Dotter, C.P., Isaev, S. et al. Cortical development dynamics across autism spectrum disorder mouse models. Nature (2026). https://doi.org/10.1038/s41586-026-10679-1

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41586-026-10679-1

Parents, doctors, teachers, and researchers have long noticed that autism can look very different from one person to another. Some autistic children speak very little, while others develop advanced language skills. Some are highly sensitive to sounds and textures, while others are less affected. This wide variation has led scientists to ask a fundamental question: […]

The post Brain scans reveal two distinct types of autism appeared first on Knowridge Science Report.

Our governments are maiming/killing us with jabs for the sake of "biological colonialism". "At some point there were no new lands left to conquer...[so] how do you extract wealth from the middle class? You do it through iatrogenic injury".

Attorney Aaron Siri exposes the flawed safety testing of childhood vaccines, claiming that none have been tested against saline placebos. Instead, vaccines are compared to older vaccines, creating a misleading safety profile. He argues that significant adverse event rates exist, asserting that these practices endanger children's health and lack proper testing validation.

President Trump announces that childhood vaccinations and medications cause autism, citing the Amish community's low autism rates due to their lack of vaccination. His announcement aligns with alternative medical opinions on this for the past several decades.